Vision loss linked to depression

Article

American adults who lose their eyesight are almost twice as likely to be depressed as other adults, an analysis of data from a large federal health survey has revealed.

 

American adults who lose their eyesight are almost twice as likely to be depressed as other adults, an analysis of data from a large federal health survey has revealed.

To assess the relationship between vision and depression, researchers used data from the 2005-2008 National Health and Nutrition Examination Survey (NHANES), which included 10,480 adults. This recurring, nationally representative survey nation’s health is sponsored by the Centers for Disease Control and Prevention (CDC).

NHANES asked participants about their ability to perform 6 vision-related functional tasks such as reading a newspaper and finding items on a crowded shelf. Depression was assessed with a 9-question screening test, the Patient Health Questionnaire. The estimated weighted (crude) prevalence of depression in adults aged 20 years or older with self-reported visual function loss was 11.3% (95% confidence interval [CI], 9.7% - 13.2%) compared with 4.8% in adults without any self-reported functional impairment (95% CI, 4.0% - 5.7%).

"The uniqueness of this study is that it was done in a national sample. NHANES samples people nationally and from all adult age groups. We were not just looking at [the] Medicare population," said Jinan B. Saaddine, MD, MPH study coauthor.

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.